on 25 Feb 2020
Last Applicant/ Owned by
A-1030 Wien
AT
Serial Number
79256903 filed on 19th Dec 2018
Registration Number
5993170 registered on 25th Feb 2020
Correspondent Address
Frank Terranella
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"RAAS"
Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment Read More
Medical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system
No 79256903
No Service Mark
No 401975
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 04th Nov 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 26th Nov 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 17th Jul 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 25th Jun 2020 | FINAL DISPOSITION PROCESSED |
| 25th Jun 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 25th May 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 25th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
| 10th Dec 2019 | PUBLISHED FOR OPPOSITION |
| 10th Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Nov 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
